Mounjaro Success Stories Before & After: Real Timeline

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro Success Stories - UK Price £124.99

Real Mounjaro before and after UK transformations at the cheapest price from £124.99 plus £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Mounjaro Success Stories Before And After: Real Timeline

Published on: June 03, 2026

Searching for mounjaro success stories before and after UK evidence? At Cured Pharmacy, we've supported hundreds of patients through their tirzepatide journey, and the clinical data consistently shows remarkable outcomes when combined with lifestyle changes. Understanding realistic timelines helps set appropriate expectations before starting treatment.

What the Clinical Trials Show: Real Mounjaro Success Stories Before and After Data

The SURMOUNT-1 trial provides the most comprehensive mounjaro success stories before and after evidence available. Over 72 weeks, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5%, whilst those on the 10mg dose averaged 21.4% reduction [1]. These results represent the largest weight reductions observed in any obesity medication trial to date.

Importantly, 63% of participants on the highest dose achieved at least 20% total body weight loss — a threshold previously only achievable through bariatric surgery [1]. The trial enrolled over 2,500 adults with obesity or overweight with weight-related comorbidities, making the data highly representative of real-world UK patient populations.

At Cured Pharmacy, we've observed outcomes consistent with these trial results among our patients who maintain the prescribed regimen and lifestyle modifications. Mounjaro is available from £124.99 following assessment by our UK-registered prescribers, who evaluate suitability based on your individual medical history and weight loss goals.

Week-by-Week Mounjaro Timeline: What to Expect in Your First 3 Months

Understanding the mounjaro weight loss timeline UK patients experience helps set realistic expectations. The medication follows a structured dose escalation schedule designed to minimise gastrointestinal side effects whilst optimising efficacy.

During weeks 1-4 on the 2.5mg starter dose, most patients notice reduced appetite and smaller portion sizes, with average weight loss of 1-3% of starting body weight [2]. This initial phase focuses on tolerability rather than maximum efficacy. Weeks 5-8 involve escalation to 5mg, where weight loss typically accelerates to 0.5-1kg per week as the medication reaches more therapeutic levels [2].

By weeks 9-12 on the 7.5mg dose, patients commonly report significant appetite suppression and sustained weight reduction. Clinical trial data shows average weight loss of 6-8% by month three, though individual responses vary based on adherence, baseline metabolism, and lifestyle factors [1]. Your UK prescriber will monitor progress and adjust dosing accordingly.

Managing Early Side Effects

The gradual dose escalation minimises but doesn't eliminate gastrointestinal effects. Nausea affects approximately 25-30% of patients during the first month, typically resolving as the body adapts [2]. Eating smaller meals, avoiding high-fat foods, and staying well-hydrated significantly improves tolerability. If side effects persist beyond the initial adjustment period, your prescriber may slow the escalation schedule or recommend supportive measures.

Month 4-6: Accelerated Results and Dose Optimisation

The period between months 4-6 represents the acceleration phase for most patients. As doses increase to 10mg or 12.5mg, the dual GIP/GLP-1 receptor activation reaches optimal therapeutic levels, producing more pronounced metabolic effects [3].

SURMOUNT-1 data demonstrates that by week 24 (6 months), participants on maintenance doses achieved average weight loss of 15-17% from baseline [1]. This translates to approximately 13-18kg for someone starting at 100kg. Importantly, the weight loss curve remains steep during this period, indicating continued efficacy rather than plateau.

During this phase, patients typically report stabilised appetite control, improved satiety from smaller portions, and reduced food cravings. Metabolic improvements become evident through blood work, with significant reductions in HbA1c, fasting glucose, and lipid profiles commonly observed [3]. Your UK prescriber will conduct regular reviews to assess progress and optimise your treatment plan.

Treatment Active Ingredient Average Weight Loss (Clinical Trials) Starting Price
Mounjaro Tirzepatide 22.5% at 72 weeks From £124.99
Wegovy Semaglutide 14.9% at 68 weeks From £69.00
Saxenda Liraglutide 8% at 56 weeks From £68.00
Orlistat Orlistat 3-5% at 12 months From £32.00

Long-Term Mounjaro Results: 9-12 Month Outcomes

The most impressive mounjaro success stories before and after transformations emerge between months 9-12. SURMOUNT-1 participants maintained on the 15mg dose achieved their peak average weight reduction of 22.5% at 72 weeks, with many continuing to lose weight beyond the one-year mark [1].

Crucially, the trial data shows sustained weight loss rather than regain during the maintenance phase. Approximately 91% of participants maintained clinically significant weight loss (≥5% body weight) at 72 weeks, and 63% achieved ≥20% reduction [1]. These long-term outcomes surpass those observed with previous GLP-1 receptor agonists like semaglutide.

Real-world UK patient experiences align with trial data when treatment is combined with sustainable lifestyle modifications. Our superintendent pharmacist Tarun Kumar notes that patients who establish consistent eating patterns, incorporate regular physical activity, and attend follow-up consultations achieve the most durable results. Mounjaro is not a standalone solution but rather a powerful tool within a comprehensive weight management programme.

Maintaining Results After Reaching Goal Weight

Weight maintenance requires ongoing treatment in most cases. Clinical evidence shows that discontinuing tirzepatide typically results in gradual weight regain, similar to other obesity medications [3]. Your UK prescriber will work with you to determine the appropriate maintenance dose and duration based on your individual response, comorbidity improvements, and long-term health goals. Many patients transition to lower maintenance doses once target weight is achieved.

Comparing Mounjaro Success Stories to Other Weight Loss Treatments

When evaluating tirzepatide before and after results against alternative treatments, the clinical data reveals significant differences in efficacy. The STEP 1 trial of semaglutide (the active ingredient in Wegovy) demonstrated average weight loss of 14.9% at 68 weeks [4], compared to tirzepatide's 22.5% at 72 weeks [1].

Liraglutide (Saxenda), an earlier-generation daily GLP-1 injection, produces more modest results of approximately 8% average weight loss over 56 weeks [5]. Oral medications like orlistat typically achieve 3-5% weight reduction, significantly lower than injectable GLP-1 treatments but useful for patients who prefer non-injectable options or have contraindications to GLP-1 therapies.

The dual receptor mechanism of tirzepatide appears to confer superior efficacy compared to GLP-1-only agonists. Both GIP and GLP-1 pathways contribute to appetite regulation, insulin secretion, and energy expenditure, producing additive effects on weight reduction [3]. However, individual patient factors including tolerability, injection preferences, and cost considerations influence treatment selection.

Realistic Expectations: Factors That Influence Your Mounjaro Results

Whilst clinical trial data provides valuable benchmarks, individual mounjaro average weight loss per week varies considerably. Starting BMI significantly impacts absolute weight loss — patients with higher baseline weights typically lose more kilograms, though percentage reductions remain comparable [1].

Adherence to the prescribed injection schedule critically determines outcomes. Missing doses or inconsistent timing reduces therapeutic levels and diminishes efficacy. Similarly, dietary choices matter: whilst tirzepatide reduces appetite, consuming calorie-dense processed foods can partially offset the medication's effects. Patients who combine treatment with whole-food diets and regular physical activity consistently achieve superior results [2].

Metabolic factors including age, hormonal status, medication interactions, and underlying conditions also influence response rates. Approximately 10-15% of patients respond suboptimally to tirzepatide, achieving less than 10% weight reduction [1]. Your UK prescriber will monitor progress through regular consultations and adjust treatment if initial response is inadequate. Alternative medications or combination approaches may be considered for partial responders.

Setting Achievable Goals

Evidence-based weight loss targets recommend aiming for 0.5-1kg per week during active treatment phases, with slower rates during maintenance. Rapid weight loss exceeding 1.5kg weekly may indicate inadequate nutrition and should be discussed with your prescriber. Sustainable weight management focuses on gradual, consistent progress rather than dramatic short-term results. Our clinical team at Cured Pharmacy supports patients in establishing realistic milestones aligned with trial data and individual circumstances.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
  3. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102 [accessed 13 August 2026]
  4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary and are not guaranteed. Weight loss outcomes depend on adherence to prescribed treatment, lifestyle modifications, and individual metabolic factors.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How much weight can you lose in the first month on Mounjaro?
Most patients lose 1-3% of their starting body weight during the first month on the 2.5mg starter dose, which typically equates to 1-3kg for someone weighing 100kg. Individual results vary based on adherence and baseline metabolism.
Do mounjaro success stories before and after show continued weight loss after 6 months?
Yes, clinical trial data demonstrates continued weight reduction through 72 weeks, with peak average weight loss of 22.5% achieved at the study endpoint. Most patients continue losing weight beyond the 6-month mark when maintained on therapeutic doses.
What percentage of Mounjaro patients achieve significant weight loss?
In SURMOUNT-1, 91% of participants on the 15mg dose achieved clinically significant weight loss (≥5% body weight), whilst 63% achieved ≥20% reduction at 72 weeks. These percentages represent patients who completed the full trial protocol.
How does Mounjaro compare to Wegovy for weight loss results?
Mounjaro (tirzepatide) produced 22.5% average weight loss at 72 weeks compared to Wegovy's (semaglutide) 14.9% at 68 weeks in respective clinical trials. The dual GIP/GLP-1 mechanism appears to confer superior efficacy, though both are highly effective treatments.
Will I regain weight if I stop taking Mounjaro?
Clinical evidence shows that discontinuing tirzepatide typically results in gradual weight regain, similar to other obesity medications. Ongoing treatment is usually required to maintain weight loss, though some patients transition to lower maintenance doses after achieving their goals.
What is the typical mounjaro weight loss timeline UK patients experience?
UK patients following the standard dose escalation typically lose 1-3% in month one, 6-8% by month three, 15-17% by month six, and up to 22.5% by month 12-18 on maximum doses. Individual timelines vary based on adherence and metabolic factors.
Can I see mounjaro results week by week, or is weight loss gradual?
Weight loss occurs gradually and consistently rather than in dramatic weekly drops. Most patients lose 0.5-1kg per week during active treatment phases, with some variation week-to-week due to fluid fluctuations and hormonal factors. Tracking monthly trends provides more meaningful progress indicators than weekly measurements.
Do I need to diet and exercise to see mounjaro before and after results?
Whilst tirzepatide produces weight loss independently, combining treatment with balanced nutrition and regular physical activity significantly improves outcomes. Clinical trials included lifestyle counselling alongside medication, and real-world results are optimised when patients adopt sustainable healthy behaviours.
How long does it take to see Mounjaro success stories results in the UK?
Most UK patients report noticeable weight loss within 4-8 weeks of starting Mounjaro, with significant results typically visible after 12-16 weeks. Cured Pharmacy provides ongoing prescriber support throughout your journey to help you achieve success stories like those shared by our patients.
Are Mounjaro before and after results typical for UK patients?
Clinical studies show UK patients lose an average of 15-20% body weight over 72 weeks on Mounjaro. Individual results vary based on starting weight, diet, exercise and adherence to treatment, but success stories from Cured Pharmacy patients reflect these clinical outcomes.
Can I share my Mounjaro success story with Cured Pharmacy?
Yes, we welcome patients to share their Mounjaro before and after experiences to inspire others in the UK. Contact Cured Pharmacy directly to discuss sharing your transformation story while maintaining your privacy and confidentiality throughout the process.
Do Mounjaro success stories in the UK include NHS patients?
Most UK success stories come from private prescriptions as NHS Mounjaro availability remains limited to specific diabetes cases. Cured Pharmacy offers affordable private prescriptions from £124.99, making real transformations accessible to more UK patients seeking weight loss results.
What makes Mounjaro before and after results better than other weight loss treatments?
Mounjaro combines GIP and GLP-1 receptor activation, leading to superior weight loss compared to single-hormone treatments in clinical trials. Cured Pharmacy patients report better appetite control and sustained results, contributing to the impressive success stories documented across the UK.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.